Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML) – a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US
Schoenbek K et al. Leuk Lymphoma, September 2026 (epub ahead of print)
Link to full abstract